IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

该SBIR第二阶段合同的目的是开发一种廉价且易于使用的仪器， 能够测量低ppm水平（至少<5ppm）的通常用于药物制剂中的一系列金属 行业该仪器将与反应和纯化设备位于同一地点，其中金属去除 进行，并且优选地，可经受与连续监测相关联的金属杂质的连续监测。 处理操作。

The purpose of this SBIR Phase II contract is to develop an inexpensive and easy to use instrument that will be capable of measuring low ppm levels (at least <5 ppm) of a range of metals typically used in the pharmaceutical industry. The instrument would be co-located with the reaction and purification equipment where metal removal is performed, and preferably, amenable to continuous monitoring of metal impurities associated with continuous processing operations.